equations logistic regression modeling was used to generate independent variables associated with procedural success and procedural complications. Results: During the study period, CTO PCI represented 3.8% of the total PCI volume for stable coronary artery disease (22,365 of 594,510). Overall, patients undergoing CTO PCI required higher contrast volume and fluoroscopy time and had lower procedural success (59% vs. 96%, P< 0.001) and higher MACE rate (1.6% vs. 0.8%, P< 0.001) than non CTO patients. On multivariable analysis, several parameters (including older age, current smoking, prior MI, prior CABG, prior peripheral arterial disease, prior cardiac arrest, right coronary artery CTO target vessel, and less operator experience), were associated with lower likelihood of CTO PCI procedural success, while operators' annual CTO PCI volume was associated with improved success without significant increase in major complications. Conclusions: CTO PCI is currently performed infrequently in the US for stable coronary artery disease and is associated with lower procedural success and higher complication rates compared with non-CTO PCI. Procedural success was associated with several patient factors and operator experience.
Background: We evaluated the in-hospital and the long-term clinical and angiographic outcomes of drug-eluting stents (DES) deployed in true versus false lumen of successfully crossed chronic total occlusions (CTO) Methods: Between August 2011 and October 2012, 157 consecutive patients with 173 CTO lesions were successfully recanalized in a single center. All procedures were guided with intravascular ultrasound (IVUS). After successful guidewire crossing, lesions were classified according to IVUS evaluation into 2 groups; (1) true lumen group and, (2) subintimal stenting group; and compared with regards to in-hospital and long term clinical outcomes Results: In 154 lesions, DES were deployed in the true lumen; and in 19 (11%) lesions, DES were deployed in the subintimal space (95% confidence interval: 6.3% to 15.6%) with a success rate of 96 % and 82.4%, in antegrade and retrograde approaches, respectively. IVUS showed that the prevalence of dissection was two times and intramural hematoma (IMH) was three times as higher in the subintimal stenting group (p< 0.001 and p< 0.01, respectively).Subintimal stenting was associated with a significant increase in minor perforations 6/19 (31.6 % vs. 8.4%, p¼0 .002), all were managed conservatively. Kaplan-Meier analysis revealed a similar rates of binary restenosis and target lesion revascularization between groups (p¼0.73 and p¼0.97, respectively).Six patients (4.6%, 6 / 129 patients) in the true lumen group and none in the subintimal group died at one year
IVUS Findings
Conclusions: Subintimal stent deployment in CTO segments, using second generation DES with IVUS guidance, carries a similar success rate and long-term angiographic and clinical outcomes as true lumen stenting Yale University School of Medicine, New Haven, CT Background: Transradial access is often used in percutaneous coronary intervention(PCI) for chronic total occlusions (CTO), however, its efficacy and safety in this setting have received limited study. Methods: We compared the technique and outcomes of transradial vs. transfemoral access among 650 CTO PCI cases performed between January 2012 and March 2014 at 6 US centers. Results: Most patients were men (87%) with high frequency of diabetes mellitus (42%) and prior coronary artery bypass graft surgery (36%). The CTO target vessel was the right coronary (59%), left anterior descending (20%), or circumflex (17%) artery. TR access was used in 110 (17%) of the 650 cases, as follows: bilateral radial access (63%); bilateral radial access plus unilateral or bilateral femoral access (7%); unilateral radial access plus unilateral or bilateral femoral access (26%); and unilateral radial access (4%). Six and eight French guide catheters were used through the radial and femoral artery, respectively. Compared to transfemoral, transradial cases had similar technical (92.6% vs. 93.0%, p¼0.87) and procedural (91.1% vs. 90.0%, p¼0.95) success and major complication rates (1.7% vs 1.8 %, p¼0.99). However, transradial access was associated with higher mean procedure (142AE83 vs. 120AE60 min, p¼0.008) and fluoroscopy (58AE40 vs. 49AE31 min, p< 0.026) time, and number of crossing approach changes (0.7AE1.0 vs. 0.5AE0.7, p¼0.008). Values are mean AE SD, median (interquartile range), or n (%). CSA indicates cross-sectional area; EEM, external elastic membrane; IVUS, intravascular ultrasound.* immediately after wiring or after pre-dilation with a 1 to 2.0-mm balloon.{ final guidewire position in a false lumen with subsequent stent deployment in subintimal space.
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5 :00 PM-7:00 PM Conclusions: Transradial CTO PCI can be performed with similar success and complication rates with transfemoral CTO PCI, but is associated with longer procedural and fluoroscopy times. Background: Little is known about the clinical outcomes and optimal treatment strategies of chronic total occlusion (CTO) with well-developed collateral circulation.
Methods: We screened 2,024 consecutive patients with at least one CTO detected on coronary angiogram. Of these, we analyzed data from 738 patients with Rentrop 3 grade collateral circulation who were treated with medical therapy alone (n¼236), coronary artery bypass grafting (n¼170) or percutaneous coronary intervention (PCI) (n¼332; 80.1% successful). Patients who underwent revascularization and medical therapy (revascularization group, n ¼502) were compared to those who underwent medical therapy alone (medication group, n¼236) in terms of cardiac death and major adverse cardiac events (MACE), defined as the composite of cardiac death, myocardial infarction, or repeat revascularization. Results: During a median follow-up duration of 42 months, multivariate analysis revealed a significantly lower incidence of cardiac death (hazard ratio [HR] 0.29; 95% confidence interval [CI] 0.15 to 0.58; p< 0.01) and MACE (HR 0.32; 95% CI 0.21 to 0.49; p< 0.01) in the revascularization group compared to the medication group. After propensity score matching, the incidence of cardiac death (HR 0.27; 95% CI 0.09 to 0.80; p¼0.02) and MACE (HR 0.44; 95% CI 0.23 to 0.82; p¼0.01) were still significantly lower in the revascularization group than in the medication group.
Conclusions:
In patients with coronary CTO and well-developed collateral circulation, aggressive revascularization may reduce the risk of cardiac mortality and MACE. These findings need to be confirmed in randomized controlled trials.
TCT-198
Retrograde Background: The aim of this study was to describe the five-year European experience of retrograde percutaneous coronary interventions (PCI) revascularization for complex chronic total occlusions (CTOs) of coronary arteries. Methods: Demographic data, procedural outcomes and in-hospital clinical events were collected on 1582 consecutive lesions of 1395 patients enrolled between January 2008 and December 2012 having retrograde CTO PCI at 44 European medical centers by 45 experienced interventionalist operators. A retrograde J-CTO score was used to better describe success according to lesion difficulty. Data about clinical follow-up were collected. Results: Patients mean age was 62.0 AE 10.4 years. During the procedure the retrograde approach was used as first line strategy in 76.2% of cases, while immediately after antegrade failed approach in 23.8% of cases. Procedural success was achieved in 75.3% of cases. A major complication occurred in 16 patients (1.0%). In multivariable analysis, age of the patient (per 10-year increase) (OR:1.19, 95%CI:1.03-1.34; p¼0.02), lower operator volume (OR:3.00, 95%CI:2.41-4.21; p< 0.001) and increased retrograde J-CTO score (OR:0.42, 95%CI:0.24-0.74; p< 0.001) were recognized as independent predictors of procedural failure. The mean follow-up period was 24.7 AE 15.0 months. Major adverse cardiac and cerebral events (MACCE) occurred in 13.6% of cases (cardiac death 1.9%, myocardial infarction 3.2%, stroke 0.6% and target vessel revascularization 13%). By multivariate Cox regression, the independent predictors of MACCE were: male gender (HR:0.47, 95% CI:0.30-0.74; p¼0.01); prior myocardial infarction (HR:1.45, 95%CI:1.01-2.09; p¼0.04); number of previous attempts (HR:1.63, 95%CI:1.36-1.95; p< 0.001); CTO length (HR:1.01, 95%CI:1.00-1.02; p¼0.004); and total stent length (HR:0.98, 95% CI:0.97-0.98;p< 0.001). Conclusions: In Europe among selected centers dedicated to CTO revascularization, retrograde approach was performed over a 5-year period in 16.5% of these patients. 
